bio floyds pharma tevafate

TEVAFATE

FDA- approved for treatment of Duodenal ulcers.Co-factor for an important mucosal growth factor. Provides mucosal protection by physical coating the mucosa.Prevents recurrent bleeding in stressulcers. Prevents futher degradation of ulcer by acid.Duodenal and gastic ulcer bile reflux chronic gastritis postprandial reflux oesophagitis stress ulcer.






FDA- approved for treatment of Duodenal ulcers.Co-factor for an important mucosal growth factor. Provides mucosal protection by physical coating the mucosa.Prevents recurrent bleeding in stressulcers. Prevents futher degradation of ulcer by acid.Duodenal and gastic ulcer bile reflux chronic gastritis postprandial reflux oesophagitis stress ulcer.

Tevafate